NCT06712511 The Effect of Coffee on Energy Expenditure and Caffeine Metabolism
| NCT ID | NCT06712511 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-10-23 |
| Primary Completion | 2029-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-10-23 with a primary completion date of 2029-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Obesity is a risk factor for chronic diseases, and improving energy expenditure is a way to prevent and treat obesity. The purpose of this project is to explore the relationship between the effect of coffee on energy expenditure and caffeine metabolism, which has important significance in the rational application of caffeine.
Eligibility Criteria
Inclusion Criteria： * Healthy adults. * Must be able to drink coffee. Exclusion Criteria: * Diabetes. * Hypoglycemia. * Gout. * Osteoporosis. * Gastric ulcer. * Pancreatitis. * Intestinal obstruction. * Blood phobia. * Pathological hypo or hyper tension. * Impaired glucose tolerance. * Claustrophobia. * HIV,etc.
Contact & Investigator
John R Speakman, PhD
STUDY CHAIR
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Frequently Asked Questions
Who can join the NCT06712511 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06712511 currently recruiting?
Yes, NCT06712511 is actively recruiting participants. Contact the research team at j.speakman@abdn.ac.uk for enrollment information.
Where is the NCT06712511 trial being conducted?
This trial is being conducted at Shenzhen, China.
Who is sponsoring the NCT06712511 clinical trial?
NCT06712511 is sponsored by Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences. The principal investigator is John R Speakman, PhD at Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences. The trial plans to enroll 60 participants.